Interleukin-12p40 variants with improved stability

Details for Australian Patent Application No. 2006332138 (hide)

Owner Merck Patent GmbH

Inventors Lo, Kin-Ming; McKenzie, Suzanne P.; Webster, Gordon D.; Stein, Pascal Andre

Agent Davies Collison Cave

Pub. Number AU-B-2006332138

PCT Pub. Number WO2007/076933

Priority 60/755,382 30.12.05 US

Filing date 20 December 2006

Wipo publication date 12 July 2007

Acceptance publication date 22 March 2012

International Classifications

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 15/24 (2006.01) Mutation or genetic engineering

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

21 August 2008 PCT application entered the National Phase

  PCT publication WO2007/076933 Priority application(s): WO2007/076933

22 March 2012 Application Accepted

  Published as AU-B-2006332138

19 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006332146-Copolymers based on unsaturated monocarboxylic or dicarboxylic acid derivatives and oxyalkylene glycol alkenyl ethers, process for preparing them and their use

2006332124-3 , 5-substitgammaued piperidine compounds as renin inhibitors